Please login to the form below

Not currently logged in
Email:
Password:

David Barratt launches new consultancy

Former CEO of Euro RSCG Life, David Barratt, has launched Healthcare Communications Consultancy (HCC), a specialist management consultancy

Former CEO of Euro RSCG Life, David Barratt, has launched Healthcare Communications Consultancy (HCC), a specialist management consultancy serving both network and independent agencies and working with procurement departments within global pharmaceutical companies.

In late 2007, Barratt took-over the helm at Euro RSCG Life.  Fifteen months later, he set up a second agency, Health 4 Brands. Following a reorganisation in mid-2010, Barratt moved on to set-up his own company.

"The demands on agency leaders have increased dramatically over the last five years. As a result, running accounts and managing stretched teams plus continually having to fire fight, means that heads of agencies often do not have enough time to do the important strategic thinking and general management that is necessary. As someone who has set up two agencies and successfully turned around two others, I can best use my experience to help a wide variety of companies offering advertising, design, med comms/ed, PR and digital services. I get huge satisfaction from helping agencies to develop and grow," said Barratt.

Prior to Euro RSCG Life, Barratt was MD of Lowe Azure and Lowe Fusion, and MD of ApotheCom Europe. He also ran his own agency for 14 years.

2nd March 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics